Sensex rejig: Tata Motors to replace Dr Reddy’s with an inflow of $124 million

In the latest round of rejig of the 30-share pack, Tata Group’s automobile arm Tata Motors will replace the drug major Dr Reddy’s Laboratories, said an report from Nuvama Alternative and Quantitative Research.

Generated by Feedzy